About
GMIPLUS® Immuno Protein
GMIPLUS® is an immune-modulatory protein derived from Ganoderma Microsporum.
It is cultivated by S. cerevisiae through a sophisticated biological, genetic medicine process.
It has multiple immune modulation and anti-cancer effects.
Clinical shreds of evidence have shown its immunologic balancing and enhancing metabolism in further it can inhibit multiple cancers stem cells.
The first brewer's yeast immunoregulatory protein
FIP-GMIPLUS®
verified by transnational research
Among the different members of this migratory Ganoderma lucidum immunoregulatory protein family, the FIP-GMI immunomodulatory protein purified from S. cerevisiae has been researched and developed by an international team.
The mechanism of action of the yeast immunoregulatory protein FIP is currently a subject of active research in the biomedical community! Based on the results of Taiwan and cross international research institutes, we found that the yeast immunomodulatory protein FIP-GMI can regulate cells containing T cells, B cells, and dendritic cells in the human body. Through the role and balance of Cellular Immunity, which in turn achieves physiological balancing and repairment.
GMIPLUS® Immuno Protein
8 Major Features
Anti-inflammatory
Anti-oxidation
Two-ways immune regulation
Strengthen the nervous system, promote growth, and repair with the regeneration of brain nerve synapses.
Protect the gut
External use can accelerate wound repair
Anti-cancers (anti-tumors) and inhibit cancer cells metastasis
Benefit diabetes patients improve blood sugar regulation
GMIPLUS® Immuno Protein
Main efficacy and Research Patents
Obtained medicinal evidence for the treatment of cancer cell invasion and metastasis: NIH experiments in the United States have found inhibitory and killing effects on various cancer cell lines, including non-small cell lung cancer and head-neck squamous cells. Lymphoma, breast cancer, brain cancer, bladder cancer, liver cancer, colorectal cancer, rectal cancer, colon cancer, melanocyte carcinoma, blood cancer, and kidney cancer.
It can improve blood sugar regulation and liver triglyceride accumulation.
It also has partial anti-inflammatory effects.
Promotes neurite outgrowth and repair and regenerates the nervous system.
The Sun Yat-Sen University of Medical Research has confirmed that GMIPLUS® not only can significantly inhibit cancer stem cell proliferation, invasion, and metastasis and suppress the resistance of cancer stem cells with cisplatin. GMIPLUS® is used to feed nude mice (immunized hypoxic mice) that have been previously inoculated with cancer stem cells, even Slowing the rate of tumor growth. It also has partial anti-inflammatory effects.
Blocking the IL6/Stat3 message transmission pathway is one of the mechanisms by which GMIPLUS® inhibits cancer stem cells.
Taiwan University, Yangming University, ITRI Health Center, and several scientific research units validated!
The CRO (commissioned research institute) completed the acute toxicity and sub-chronic toxicity tests and obtained international authoritative patents.
